Compare ABOS & GLDG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.
GoldMining Inc is a mineral exploration company with a focus on the acquisition, exploration, and development of projects in Colombia, Brazil, the United States, Canada, and Peru. The principal projects are its La Mina Gold project and its Titiribi Gold-Copper project, located in Colombia, Crucero project, located in Peru, Sao Jorge, Batistao, Boa Vista, located in Brazil, Yellowknife Gold Project, located in the Northwest Territories, Canada, and other projects. The company earns maximum revenue from Canada.